Percutaneous Management of Malignant Fluid Collections
Overview
Authors
Affiliations
The development of a pleural effusion or ascites in patients with underlying malignancy typically heralds end-stage disease and often results in a significant reduction in the patient&'s quality of life. The goal of treatment is the safe and effective palliation of symptoms with minimal inconvenience to the patient. Malignant fluid collections in the chest and abdomen are amenable to percutaneous management with either intermittent thoracentesis or paracentesis or by placement of temporary or permanent drainage catheters.
Kimmerling R, Stevens M, Olcum S, Minnah A, Vacha M, LaBella R Commun Biol. 2022; 5(1):1295.
PMID: 36435843 PMC: 9701192. DOI: 10.1038/s42003-022-04270-3.
Chronic peritoneal indwelling catheters for the management of malignant and nonmalignant ascites.
Caldwell J, Edriss H, Nugent K Proc (Bayl Univ Med Cent). 2018; 31(3):297-302.
PMID: 29904292 PMC: 5997061. DOI: 10.1080/08998280.2018.1461525.
Meier M, Mortensen F, Torp Madsen H Acta Radiol Open. 2015; 4(7):2058460115579934.
PMID: 26346641 PMC: 4548747. DOI: 10.1177/2058460115579934.
Godazandeh G, Qasemi N, Saghafi M, Mortazian M, Tayebi P J Thorac Dis. 2013; 5(2):141-4.
PMID: 23585939 PMC: 3621929. DOI: 10.3978/j.issn.2072-1439.2013.02.02.
Malignant ascites: pathophysiology and treatment.
Cavazzoni E, Bugiantella W, Graziosi L, Franceschini M, Donini A Int J Clin Oncol. 2012; 18(1):1-9.
PMID: 22460778 DOI: 10.1007/s10147-012-0396-6.